about
Nitroxide-Based Macromolecular Contrast Agents with Unprecedented Transverse Relaxivity and Stability for Magnetic Resonance Imaging of Tumors.Big Potential from Small Agents: Nanoparticles for Imaging-Based Companion Diagnostics.Multifunctional nanomedicine with silica: Role of silica in nanoparticles for theranostic, imaging, and drug monitoring.Regenerative Medicine Therapies for Targeting Neuroinflammation After StrokeImaging Nanomedicine-Based Drug Delivery: a Review of Clinical Studies
P2860
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh
2016年學術文章
@zh-hant
name
Clinically Approved Nanoparticle Imaging Agents.
@en
type
label
Clinically Approved Nanoparticle Imaging Agents.
@en
prefLabel
Clinically Approved Nanoparticle Imaging Agents.
@en
P2093
P2860
P1476
Clinically Approved Nanoparticle Imaging Agents.
@en
P2093
Avnesh S Thakor
Erik Mittra
Jesse V Jokerst
Jos L Campbell
Pejman Ghanouni
Sanjiv S Gambhir
P2860
P304
P356
10.2967/JNUMED.116.181362
P407
P577
2016-10-13T00:00:00Z